Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands

Bioorganic & Medicinal Chemistry
2015.0

Abstract

The P2Y14 receptor (P2Y14R) is a Gi protein-coupled receptor that is activated by uracil nucleotides UDP and UDP-glucose. The P2Y14R structure has yet to be solved through X-ray crystallography, but the recent agonist-bound crystal structure of the P2Y12R provides a potentially suitable template for its homology modeling for rational structure-based design of selective and high-affinity ligands. In this study, we applied ligand docking and molecular dynamics refinement to a P2Y14R homology model to qualitatively explain structure-activity relationships of previously published synthetic nucleotide analogues and to probe the quality of P2Y14R homology modeling as a template for structure-based design. The P2Y14R model supports the hypothesis of a conserved binding mode of nucleotides in the three P2Y12-like receptors involving functionally conserved residues. We predict phosphate group interactions with R253(6.55), K277(7.35), Y256(6.58) and Q260(6.62), nucleobase (anti-conformation) π-π stacking with Y102(3.33) and the role of F191(5.42) as a means for selectivity among P2Y12-like receptors. The glucose moiety of UDP-glucose docked in a secondary subpocket at the P2Y14R homology model. Thus, P2Y14R homology modeling may allow detailed prediction of interactions to facilitate the design of high affinity, selective agonists as pharmacological tools to study the P2Y14R.

Knowledge Graph

Similar Paper

Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands
Bioorganic & Medicinal Chemistry 2015.0
Structure−Activity Relationship of Uridine 5‘<b>-</b>Diphosphoglucose Analogues as Agonists of the Human P2Y<sub>14</sub> Receptor
Journal of Medicinal Chemistry 2007.0
Molecular dynamics simulation of the P2Y14 receptor. Ligand docking and identification of a putative binding site of the distal hexose moiety
Bioorganic &amp; Medicinal Chemistry Letters 2007.0
Molecular recognition in the P2Y14 receptor: Probing the structurally permissive terminal sugar moiety of uridine-5′-diphosphoglucose
Bioorganic &amp; Medicinal Chemistry 2009.0
Molecular Modeling of the Human P2Y<sub>2</sub> Receptor and Design of a Selective Agonist, 2‘-Amino-2‘-deoxy-2-thiouridine 5‘-Triphosphate
Journal of Medicinal Chemistry 2007.0
Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y<sub>2</sub>Receptor
Journal of Medicinal Chemistry 2017.0
Human P2Y<sub>14</sub>Receptor Agonists: Truncation of the Hexose Moiety of Uridine-5′-Diphosphoglucose and Its Replacement with Alkyl and Aryl Groups
Journal of Medicinal Chemistry 2010.0
Structure−Activity Relationships of Uridine 5‘-Diphosphate Analogues at the Human P2Y<sub>6</sub>Receptor
Journal of Medicinal Chemistry 2006.0
5-OMe-UDP is a Potent and Selective P2Y<sub>6</sub>-Receptor Agonist
Journal of Medicinal Chemistry 2010.0
Human P2Y<sub>6</sub> Receptor:  Molecular Modeling Leads to the Rational Design of a Novel Agonist Based on a Unique Conformational Preference
Journal of Medicinal Chemistry 2005.0